Literature DB >> 24436349

Efficacy of early Mycoplasma hyopneumoniae vaccination against mixed respiratory disease in older fattening pigs.

R Del Pozo Sacristán1, A Sierens, S B Marchioro, F Vangroenweghe, J Jourquin, G Labarque, F Haesebrouck, D Maes.   

Abstract

The present field study investigated the efficacy of early Mycoplasma hyopneumoniae vaccination in a farrow-to-finish pig herd with respiratory disease late in the fattening period due to combined infections with M hyopneumoniae and viral pathogens. Five hundred and forty piglets were randomly divided into three groups of 180 piglets each: two groups were vaccinated (Stellamune Once) at either 7 (V1) or 21 days of age (V2), and a third group was left non-vaccinated (NV). The three treatment groups were housed in different pens within the same compartment during the nursery period, and were housed in different but identical compartments during the fattening period. The efficacy was evaluated using performance and pneumonia lesions. The average daily weight gain during the fattening period was 19 (V1) and 18 g/day (V2) higher in both vaccinated groups when compared with the NV group. However, the difference was not statistically significant (P>0.05). The prevalence of pneumonia was significantly lower in both vaccinated groups (V1: 71.5 and V2: 67.1 per cent) when compared with the NV group (80.2 per cent) (P<0.05). There were no significant differences between the two vaccination groups. In conclusion, in the present herd with respiratory disease during the second half of the fattening period caused by M hyopneumoniae and viral infections, prevalence of pneumonia lesions were significantly reduced and growth losses numerically (not statistically significant) decreased by both vaccination schedules.

Entities:  

Keywords:  Mycoplasmas; Pigs; Respiratory disease; Vaccines

Mesh:

Substances:

Year:  2014        PMID: 24436349     DOI: 10.1136/vr.101597

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  7 in total

1.  Experimental evaluation of Mycoplasma hyopneumoniae bacterin against a Korean M. hyopneumoniae challenge.

Authors:  SooHwan Kim; Taehwan Oh; Siyeon Yang; Hyejean Cho; Chanhee Chae
Journal:  Can J Vet Res       Date:  2021-01       Impact factor: 1.310

2.  Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae monovalent and bivalent vaccines against a dual challenge.

Authors:  Siyeon Yang; Su-Jin Park; Taehwan Oh; Hyejean Cho; Chanhee Chae
Journal:  Can J Vet Res       Date:  2020-10       Impact factor: 1.310

3.  Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins.

Authors:  Anneleen M F Matthijs; Gaël Auray; Virginie Jakob; Obdulio García-Nicolás; Roman O Braun; Irene Keller; Rémy Bruggman; Bert Devriendt; Filip Boyen; Carlos A Guzman; Annelies Michiels; Freddy Haesebrouck; Nicolas Collin; Christophe Barnier-Quer; Dominiek Maes; Artur Summerfield
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

4.  Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae.

Authors:  Anneleen Marguerite Filip Matthijs; Gaël Auray; Filip Boyen; Alexandra Schoos; Annelies Michiels; Obdulio García-Nicolás; Güliz Tuba Barut; Christophe Barnier-Quer; Virginie Jakob; Nicolas Collin; Bert Devriendt; Artur Summerfield; Freddy Haesebrouck; Dominiek Maes
Journal:  Vet Res       Date:  2019-11-08       Impact factor: 3.683

5.  A field evaluation of two vaccines against Mycoplasma hyopneumoniae infection in pigs.

Authors:  Charlotte S Kristensen; Jens Vinther; Birgitta Svensmark; Poul Bækbo
Journal:  Acta Vet Scand       Date:  2014-04-16       Impact factor: 1.695

6.  Efficacy of Mycoplasma hyopneumoniae vaccination before and at weaning against experimental challenge infection in pigs.

Authors:  Ioannis Arsenakis; Luca Panzavolta; Annelies Michiels; Rubén Del Pozo Sacristán; Filip Boyen; Freddy Haesebrouck; Dominiek Maes
Journal:  BMC Vet Res       Date:  2016-03-29       Impact factor: 2.741

7.  Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.

Authors:  Annelies Michiels; Ioannis Arsenakis; Filip Boyen; Roman Krejci; Freddy Haesebrouck; Dominiek Maes
Journal:  BMC Vet Res       Date:  2017-08-29       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.